Literature DB >> 25545597

Supporting countries in establishing and strengthening NITAGs: lessons learned from 5 years of the SIVAC initiative.

Alex Adjagba1, Kamel Senouci2, Robin Biellik3, Nyambat Batmunkh4, Pape Coumba Faye2, Antoine Durupt2, Bradford D Gessner2, Alfred da Silva2.   

Abstract

To empower governments to formulate rational policies without pressure from any group, and to increase the use of evidence-based decision-making to adapt global recommendations on immunization to their local context, the WHO has recommended on multiple occasions that countries should establish National Immunization Technical Advisory Groups (NITAGs). The World Health Assembly (WHA) reinforced those recommendations in 2012 when Member States endorsed the Decade of Vaccines Global Vaccine Action Plan (GVAP). NITAGs are multidisciplinary groups of national experts responsible for providing independent, evidence-informed advice to health authorities on all policy-related issues for all vaccines across all populations. In 2012, according to the WHO-UNICEF Joint Reporting Form, among 57 countries eligible for immunization program financial support from the GAVI Alliance, only 9 reported having a functional NITAG. Since 2008, the Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) Initiative (at the Agence de Médecine Préventive or AMP) in close collaboration with the WHO and other partners has been working to accelerate and systematize the establishment of NITAGs in low- and middle-income countries. In addition to providing direct support to countries to establish advisory groups, the initiative also supports existing NITAGs to strengthen their capacity in the use of evidence-based processes for decision-making aligned with international standards. After 5 years of implementation and based on lessons learned, we recommend that future efforts should target both expanding new NITAGs and strengthening existing NITAGs in individual countries, along three strategic lines: (i) reinforce NITAG institutional integration to promote sustainability and credibility, (ii) build technical capacity within NITAG secretariats and evaluate NITAG performance, and (iii) increase networking and regional collaborations. These should be done through the development and dissemination of tools and guidelines, and information through a variety of adapted mechanisms.
Copyright © 2014 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Advisory committee; Capacity building; Decision-making; Evidence-based policy; Health policy; Immunization; National Immunization Technical Advisory Group (NITAG); New and under-utilized vaccine; Routine immunization; Vaccine introduction

Mesh:

Year:  2014        PMID: 25545597     DOI: 10.1016/j.vaccine.2014.12.026

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  20 in total

1.  The future of immunization policies in Italy and in the European Union: The Declaration of Erice.

Authors:  Anna Odone; Gaetano M Fara; Giuseppe Giammaco; Francesco Blangiardi; Carlo Signorelli
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Age-appropriate versus up-to-date coverage of routine childhood vaccinations among young children in Israel.

Authors:  Chen Stein-Zamir; Avi Israeli
Journal:  Hum Vaccin Immunother       Date:  2017-07-11       Impact factor: 3.452

3.  Implementation strategies for the new World Mental Health Report in low-resource settings.

Authors:  Pratap Sharan
Journal:  World Psychiatry       Date:  2022-10       Impact factor: 79.683

4.  Critical success factors for routine immunization performance: A case study of Zambia 2000 to 2018.

Authors:  Katie Micek; Kyra A Hester; Chama Chanda; Roopa Darwar; Bonheur Dounebaine; Anna S Ellis; Pinar Keskinocak; Abimbola Leslie; Mwangala Manyando; Maurice Sililo Manyando; Dima Nazzal; Emily Awino Ogutu; Zoe Sakas; Francisco Castillo-Zunino; William Kilembe; Robert A Bednarczyk; Matthew C Freeman
Journal:  Vaccine X       Date:  2022-04-30

5.  Moroccan National Immunization Technical Advisory Group: a valuable asset for the national immunization program and the immunization agenda in the EMRO region.

Authors:  Imane Jroundi; Mohammed Benazzouz; Abdel Hakim Yahyane; Moulay Tahar Alaoui; Nathalie El Omeiri
Journal:  Hum Vaccin Immunother       Date:  2021-05-14       Impact factor: 3.452

6.  National, Regional and Global Certification Bodies for Polio Eradication: A Framework for Verifying Measles Elimination.

Authors:  S Deblina Datta; Rudolf H Tangermann; Susan Reef; W William Schluter; Anthony Adams
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

7.  The Role of National Immunization Technical Advisory Groups (NITAGs) in the Introduction of Inactivated Polio Vaccine: Experience of the Indonesia and Uganda NITAGs.

Authors:  Antoinette Ba-Nguz; Alex Adjagba; Toto Wisnu Hendrarto; Nelson K Sewankambo; Celia Nalwadda; Annette Kisakye
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

8.  Expansion of Vaccination Services and Strengthening Vaccine-Preventable Diseases Surveillance in Haiti, 2010-2016.

Authors:  Rania A Tohme; Jeannot Francois; Kathleen F Cavallaro; Gilson Paluku; Idrissa Yalcouye; Ernsley Jackson; Tracie Wright; Paul Adrien; Mark A Katz; Terri B Hyde; Pape Faye; Francine Kimanuka; Vance Dietz; John Vertefeuille; David Lowrance; Benjamin Dahl; Roopal Patel
Journal:  Am J Trop Med Hyg       Date:  2017-10       Impact factor: 2.345

9.  Strengthening and sustainability of national immunization technical advisory groups (NITAGs) globally: Lessons and recommendations from the founding meeting of the global NITAG network.

Authors:  Alex Adjagba; Noni E MacDonald; Inmaculada Ortega-Pérez; Philippe Duclos
Journal:  Vaccine       Date:  2017-04-26       Impact factor: 3.641

10.  Promoting research to improve maternal, neonatal, infant and adolescent health in West Africa: the role of the West African Health Organisation.

Authors:  Issiaka Sombie; Aissa Bouwayé; Yves Mongbo; Namoudou Keita; Virgil Lokossou; Ermel Johnson; Laurent Assogba; Xavier Crespin
Journal:  Health Res Policy Syst       Date:  2017-07-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.